Samsung Biologics
207940.KS
$559.32
Share price
-1.28%
Change (1 day)
-3.82%
Change (1 year)
Categories
Samsung Biologics (207940.KS) - Cash on Hand
Cash on Hand as of December 2023 : $1.58 B
According to Samsung Biologics
's latest financial reports the company has $1.58 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Samsung Biologics - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $1.58 B | -37.24% |
| 2022-12-31 | $2.53 B | 119.75% |
| 2021-12-31 | $1.15 B | 46.96% |
| 2020-12-31 | $0.78 B | 31.45% |
| 2019-12-31 | $0.59 B | -40.99% |
| 2018-12-31 | $1.01 B | 183.12% |
| 2017-12-31 | $0.35 B | -64.62% |
| 2016-12-31 | $1.00 B | 3337.66% |
| 2015-12-31 | $29.35 M | -66.6% |
| 2014-12-31 | $87.9 M |